HMGCR

3-hydroxy-3-methylglutaryl-CoA reductase

Basic information

Region (hg38): 5:75336329-75364001

Links

ENSG00000113161NCBI:3156OMIM:142910HGNC:5006Uniprot:P04035AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • muscular dystrophy, limb-girdle, autosomal recessive 28 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Statins, efficacy of; Myopathy, limb-girdle, autosomal recessive 28AD/ARMusculoskeletal; PharmacogenomicRelated to Statins, efficacy of, selection and dosage of cholesterol-lowering medications may be impacted by genotyping results; Individuals with Myopathy, limb-girdle, adult-onset have been described as responsive to medical management (with mevalonolactone)Musculoskeletal15199031; 15367547; 24001602; 36745799

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HMGCR gene.

  • Limb-girdle muscular dystrophy (1 variants)
  • Muscular dystrophy, limb-girdle, autosomal recessive 28 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HMGCR gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
missense
1
clinvar
16
clinvar
1
clinvar
18
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
2
clinvar
1
clinvar
3
Total 1 0 16 5 2

Variants in HMGCR

This is a list of pathogenic ClinVar variants found in the HMGCR region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-75342737-T-C HMGCR-related disorder Likely benign (Mar 01, 2019)3040438
5-75344257-T-A Inborn genetic diseases Uncertain significance (May 05, 2023)2523515
5-75344336-A-G Muscular dystrophy, limb-girdle, autosomal recessive 28 Pathogenic (Jun 21, 2023)2506432
5-75345615-G-A Inborn genetic diseases Uncertain significance (Mar 01, 2023)2470282
5-75347030-A-T - no classification for the single variant (-)225958
5-75347264-G-A Inborn genetic diseases Uncertain significance (Jan 11, 2023)2475710
5-75350103-C-T HMGCR-related disorder Likely benign (Apr 18, 2019)3058447
5-75350791-T-A HMGCR-related disorder Likely benign (Aug 09, 2019)3034997
5-75350838-C-T Inborn genetic diseases Uncertain significance (Aug 17, 2021)2400155
5-75350870-A-G Inborn genetic diseases Uncertain significance (Jun 14, 2023)2570007
5-75350940-A-C HMGCR-related disorder Benign (Aug 29, 2019)3053372
5-75351073-T-A Inborn genetic diseases Uncertain significance (Nov 08, 2022)2324532
5-75351155-G-C Inborn genetic diseases Uncertain significance (Jan 20, 2023)2461046
5-75351228-T-C Inborn genetic diseases Uncertain significance (May 11, 2022)2288980
5-75351540-A-G Inborn genetic diseases Uncertain significance (Jan 25, 2024)3106277
5-75351561-C-T Muscular dystrophy, limb-girdle, autosomal recessive 28 Pathogenic (Jun 21, 2023)2506434
5-75351562-G-A Muscular dystrophy, limb-girdle, autosomal recessive 28 Pathogenic (Jun 21, 2023)2506430
5-75352778-A-T Low density lipoprotein cholesterol level quantitative trait locus 3 association (Mar 20, 2008)14903
5-75354650-CCTT-C Muscular dystrophy, limb-girdle, autosomal recessive 28 Pathogenic (Jun 21, 2023)2506435
5-75354693-C-T Inborn genetic diseases Uncertain significance (Feb 11, 2022)2277124
5-75355083-A-G Inborn genetic diseases Uncertain significance (Jun 28, 2022)2298224
5-75355133-T-A Inborn genetic diseases Uncertain significance (Dec 21, 2023)3106278
5-75355435-G-A Inborn genetic diseases Uncertain significance (Jun 12, 2023)2559787
5-75355441-G-A Inborn genetic diseases Uncertain significance (Sep 08, 2023)2620865
5-75355509-G-A Muscular dystrophy, limb-girdle, autosomal recessive 28 Pathogenic (Jun 21, 2023)2506431

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HMGCRprotein_codingprotein_codingENST00000287936 1925776
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9990.001391257330141257470.0000557
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.762624980.5260.00002625816
Missense in Polyphen63184.750.340992115
Synonymous1.011471630.9000.000008171746
Loss of Function5.43645.60.1320.00000252545

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.00004630.0000462
European (Non-Finnish)0.00006170.0000615
Middle Eastern0.0001630.000163
South Asian0.00008080.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transmembrane glycoprotein that is the rate-limiting enzyme in cholesterol biosynthesis as well as in the biosynthesis of nonsterol isoprenoids that are essential for normal cell function including ubiquinone and geranylgeranyl proteins.;
Pathway
Mevalonate pathway;Bile secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Terpenoid backbone biosynthesis - Homo sapiens (human);Bisphosphonate Pathway, Pharmacodynamics;Metformin Pathway, Pharmacodynamic;Statin Pathway, Pharmacodynamics;Simvastatin Action Pathway;Pravastatin Action Pathway;Atorvastatin Action Pathway;Hyper-IgD syndrome;Cholesteryl ester storage disease;Lysosomal Acid Lipase Deficiency (Wolman Disease);Alendronate Action Pathway;Rosuvastatin Action Pathway;Lovastatin Action Pathway;Mevalonic aciduria;Wolman disease;Risedronate Action Pathway;Cerivastatin Action Pathway;Pamidronate Action Pathway;Fluvastatin Action Pathway;Smith-Lemli-Opitz Syndrome (SLOS);Chondrodysplasia Punctata II, X Linked Dominant (CDPX2);CHILD Syndrome;Desmosterolosis;Hypercholesterolemia;Steroid Biosynthesis;Zoledronate Action Pathway;Ibandronate Action Pathway;AMP-activated Protein Kinase (AMPK) Signaling;Target Of Rapamycin (TOR) Signaling;Cholesterol Biosynthesis;Sterol Regulatory Element-Binding Proteins (SREBP) signalling;Integrated Breast Cancer Pathway;SREBF and miR33 in cholesterol and lipid homeostasis;Activation of gene expression by SREBF (SREBP);Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);Demo complete;Demo;Statin Pathway;Metabolism of lipids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Squalene and cholesterol biosynthesis;Metabolism;superpathway of cholesterol biosynthesis;Metabolism of steroids;Steroids metabolism;Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);mevalonate pathway;superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) (Consensus)

Recessive Scores

pRec
0.617

Intolerance Scores

loftool
0.203
rvis_EVS
-0.49
rvis_percentile_EVS
22.36

Haploinsufficiency Scores

pHI
0.894
hipred
Y
hipred_score
0.783
ghis
0.637

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.998

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Hmgcr
Phenotype
liver/biliary system phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
hmgcrb
Affected structure
ethmoid cartilage
Phenotype tag
abnormal
Phenotype quality
shortened

Gene ontology

Biological process
cholesterol biosynthetic process;ubiquinone metabolic process;aging;response to nutrient;isoprenoid biosynthetic process;visual learning;negative regulation of striated muscle cell apoptotic process;positive regulation of cardiac muscle cell apoptotic process;coenzyme A metabolic process;sterol biosynthetic process;regulation of lipid metabolic process;positive regulation of stress-activated MAPK cascade;negative regulation of MAP kinase activity;myoblast differentiation;response to ethanol;regulation of cholesterol biosynthetic process;positive regulation of skeletal muscle tissue development;positive regulation of smooth muscle cell proliferation;protein tetramerization;oxidation-reduction process;negative regulation of wound healing;negative regulation of insulin secretion involved in cellular response to glucose stimulus;positive regulation of ERK1 and ERK2 cascade;negative regulation of blood vessel diameter
Cellular component
peroxisomal membrane;endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane
Molecular function
hydroxymethylglutaryl-CoA reductase (NADPH) activity;protein binding;hydroxymethylglutaryl-CoA reductase activity;protein homodimerization activity;coenzyme binding;protein phosphatase 2A binding;NADPH binding